Bookmark and Share

Compound Summary for: CID 5090

rofecoxib

Also known as: Vioxx; Ceoxx; 162011-90-7; MK 966; MK-966; 4-[4-(methylsulfonyl)phenyl]-3-phenylfuran-2(5H)-one; MK-0966; UNII-0QTW8Z7MCR
Molecular Formula: C17H14O4S   Molecular Weight: 314.35566   InChIKey: RZJQGNCSTQAWON-UHFFFAOYSA-N
On September 30, 2004, Merck voluntarily withdrew rofecoxib from the market because of concerns about increased risk of heart attack and stroke associated with long-term, high-dosage use.   From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Pharmacology
Biomedical Effects and Toxicity
Safety and Handling
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _